Primary Site >> Liver Cancer

Gene >> CYP3A5

Journal: Eur J Pharmacol. 2003 Apr 11;466(1-2):7-12.
Title: Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.
Author: Krusekopf, Solveigh|Roots, Ivar|Kleeberg, Ullrich
PMID: 12679136
Journal: Kaohsiung J Med Sci. 2003 May;19(5):201-7.
Title: CYP3A5*1 is an inhibitory factor for lung cancer in Taiwanese.
Author: Yeh, Kun-Tu|Chen, Jui-Chang|Chen, Chih-Mei|Wang, Yu-Fen|Lee, Tai-Ping|Chang, Jan-Gowth
PMID: 12822676
Journal: Curr Drug Metab. 2004 Jun;5(3):211-24.
Title: Cytochrome P450 gene polymorphism and cancer.
Author: Agundez, Jose A G
PMID: 15180491
Journal: Pharmacogenetics. 2004 Oct;14(10):691-700.
Title: Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa.
Author: Wojnowski, Leszek|Turner, Paul C|Pedersen, Bonnie|Hustert, Elisabeth|Brockmoller, Jurgen|Mendy, Maimuna|Whittle, Hilton C|Kirk, Greg|Wild, Christopher P
PMID: 15454734
Journal: Int J Oncol. 2005 Sep;27(3):661-7.
Title: Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.
Author: Tsunedomi, Ryouichi|Iizuka, Norio|Hamamoto, Yoshihiko|Uchimura, Shunji|Miyamoto, Takanobu|Tamesa, Takao|Okada, Toshimasa|Takemoto, Norikazu|Takashima, Motonari|Sakamoto, Kazuhiko|Hamada, Kenji|Yamada-Okabe, Hisafumi|Oka, Masaaki
PMID: 16077914
Journal: BMC Cancer. 2007 Jul 2;7:118.
Title: Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.
Author: Gervasini, Guillermo|Garcia-Martin, Elena|Ladero, Jose M|Pizarro, Rosa|Sastre, Javier|Martinez, Carmen|Garcia, Monserrat|Diaz-Rubio, Manuel|Agundez, Jose A G
PMID: 17605821
Journal: Zhonghua Gan Zang Bing Za Zhi. 2007 Sep;15(9):705-6.
Title: [A case-control study on the association of hepatocellular carcinoma with genetic polymorphisms of CYP3A5 in a highly aflatoxin B1 contaminated Guangxi area].
Author: Lu, Hai-xia|Feng, Zhen-bo|Feng, Xiao-lan
PMID: 17903382
Journal: Br J Clin Pharmacol. 2011 Aug;72(2):294-305.
Title: Population pharmacokinetic analysis of sorafenib in patients with solid tumours.
Author: Jain, Lokesh|Woo, Sukyung|Gardner, Erin R|Dahut, William L|Kohn, Elise C|Kummar, Shivaani|Mould, Diane R|Giaccone, Giuseppe|Yarchoan, Robert|Venitz, Jurgen|Figg, William D
PMID: 21392074
Journal: Tumour Biol. 2013 Aug;34(4):2357-66.
Title: CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.
Author: Wang, Bao-Sheng|Liu, Zhen|Xu, Wei-Xue|Sun, Shao-Long
PMID: 23584898
Journal: World J Gastroenterol. 2014 Jul 14;20(26):8681-90.
Title: Expression of P450 and nuclear receptors in normal and end-stage Chinese livers.
Author: Chen, Hong|Shen, Zhong-Yang|Xu, Wang|Fan, Tie-Yan|Li, Jun|Lu, Yuan-Fu|Cheng, Ming-Liang|Liu, Jie
PMID: 25024626
Journal: Cancer Res. 2015 Apr 1;75(7):1470-81.
Title: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.
Author: Jiang, Feng|Chen, Lei|Yang, Ying-Cheng|Wang, Xian-Ming|Wang, Ruo-Yu|Li, Liang|Wen, Wen|Chang, Yan-Xin|Chen, Cai-Yang|Tang, Jing|Liu, Gao-Mi-Yang|Huang, Wen-Tao|Xu, Lin|Wang, Hong-Yang
PMID: 25649767
Journal: Oncotarget. 2016 Aug 2;7(31):50612-50623.
Title: Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
Author: Zhou, Jun|Wen, Qiang|Li, Sai-Fei|Zhang, Yun-Fei|Gao, Na|Tian, Xin|Fang, Yan|Gao, Jie|Cui, Ming-Zhu|He, Xiao-Pei|Jia, Lin-Jing|Jin, Han|Qiao, Hai-Ling
PMID: 27203676
Journal: Chin Med J (Engl). 2017 Jul 20;130(14):1670-1676.
Title: Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma.
Author: Liao, Jian-Hua|Li, Chang-Can|Wu, Shao-Han|Fan, Jun-Wei|Gu, Hai-Tao|Wang, Zhao-Wen
PMID: 28685716
Journal: Oncotarget. 2018 Apr 24;9(31):22058-22068.
Title: The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma.
Author: Ashida, Ryo|Okamura, Yukiyasu|Ohshima, Keiichi|Kakuda, Yuko|Uesaka, Katsuhiko|Sugiura, Teiichi|Ito, Takaaki|Yamamoto, Yusuke|Sugino, Takashi|Urakami, Kenichi|Kusuhara, Masatoshi|Yamaguchi, Ken
PMID: 29774122
Journal: Cancer Manag Res. 2018 Jun 25;10:1713-1726.
Title: The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma.
Author: Yu, Tingdong|Wang, Xiangkun|Zhu, Guangzhi|Han, Chuangye|Su, Hao|Liao, Xiwen|Yang, Chengkun|Qin, Wei|Huang, Ketuan|Peng, Tao
PMID: 29983591
Journal: Biomed Environ Sci. 2018 Aug;31(8):586-595.
Title: Specific CYP450 Genotypes in the Chinese Population Affect Sorafenib Toxicity in HBV/HCV-associated Hepatocellular Carcinoma Patients.
Author: Guo, Xing Gang|Wang, Zhi Heng|Dong, Wei|He, Xu Dong|Liu, Fu Chen|Liu, Hui
PMID: 30231963